Globus Medical Reports Officer Changes & Comp Arrangements
Ticker: GMED · Form: 8-K · Filed: Feb 5, 2024 · CIK: 1237831
| Field | Detail |
|---|---|
| Company | Globus Medical Inc (GMED) |
| Form Type | 8-K |
| Filed Date | Feb 5, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $414,690, $460,000, $325,000, $600,000, b |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**GMED just announced executive changes and new pay deals, watch for strategic shifts.**
AI Summary
Globus Medical, Inc. filed an 8-K on February 5, 2024, to report the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. This filing also covers financial statements and exhibits. This matters to investors because changes in leadership and executive compensation can signal shifts in company strategy, financial health, or future performance, potentially impacting the stock's value.
Why It Matters
Changes in executive leadership and compensation can significantly influence a company's strategic direction and operational stability, directly affecting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Changes in key personnel can introduce uncertainty regarding future company direction and performance, warranting a medium risk assessment.
Analyst Insight
Investors should monitor subsequent filings or press releases for specific details regarding the personnel changes and compensation arrangements, as these specifics will determine the actual impact on the company's future outlook.
Key Players & Entities
- GLOBUS MEDICAL, INC. (company) — registrant
- February 5, 2024 (date) — date of earliest event reported
- 001-35621 (other) — Commission File Number
- 04-3744954 (other) — IRS Employer Identification No.
- New York Stock Exchange (other) — exchange where Class A Common Stock is registered
FAQ
What is the primary purpose of this 8-K filing by Globus Medical, Inc.?
The primary purpose of this 8-K filing, dated February 5, 2024, is to report the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', as well as 'Financial Statements and Exhibits'.
On what date was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is February 5, 2024.
What is the trading symbol and the exchange where Globus Medical, Inc.'s Class A Common Stock is registered?
Globus Medical, Inc.'s Class A Common Stock, with a par value of $.001 per share, trades under the symbol GMED and is registered on the New York Stock Exchange.
What is the business address of Globus Medical, Inc. as stated in the filing?
The business address of Globus Medical, Inc. is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403-5214.
What is the Commission File Number for Globus Medical, Inc.?
The Commission File Number for Globus Medical, Inc. is 001-35621.
Filing Stats: 600 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-05 16:45:09
Key Financial Figures
- $414,690 — Pfeil's base salary will increase from $414,690 to $460,000 and his target bonus amount
- $460,000 — e salary will increase from $414,690 to $460,000 and his target bonus amount under our a
- $325,000 — compensation program will increase from $325,000 to $600,000, both increases prorated fo
- $600,000, b — program will increase from $325,000 to $600,000, both increases prorated for the portion o
Filing Documents
- gmed-20240205x8k.htm (8-K) — 69KB
- gmed-20240205xex99_1.htm (EX-99.1) — 14KB
- 0001562762-24-000019.txt ( ) — 198KB
- gmed-20240205.xsd (EX-101.SCH) — 2KB
- gmed-20240205_lab.xml (EX-101.LAB) — 12KB
- gmed-20240205_pre.xml (EX-101.PRE) — 11KB
- gmed-20240205x8k_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated February 5, 2024 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLOBUS MEDICAL, INC. (Registrant) Dated: February 5, 2024 /s/ KELLY HULLER Kelly G. Huller Senior Vice President General Counsel and Secretary